STOCK TITAN

Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TAMPA, Fla., March 09, 2022 — Pacira BioSciences, Inc. (NASDAQ: PCRX) will participate in an analyst-led fireside chat at the Barclays Global Healthcare Conference on March 16, 2022, at 10:15 AM ET in Miami. Investors can listen to the live audio via the company's Events page, with a replay available for two weeks post-event. Pacira focuses on non-opioid treatments, offering products like EXPAREL for postsurgical pain management and ZILRETTA for osteoarthritis knee pain, aiming to reduce opioid reliance.

Positive
  • None.
Negative
  • None.

TAMPA, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Barclays Global Healthcare Conference at 10:15 AM ET on Wednesday, March 16, 2022 in Miami. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

What is the date and time of Pacira's presentation at the Barclays Global Healthcare Conference?

Pacira will present at the Barclays Global Healthcare Conference on March 16, 2022, at 10:15 AM ET.

How can I access the live audio of Pacira's fireside chat?

The live audio can be accessed on the Events page of Pacira's website.

What are the main products offered by Pacira BioSciences?

Pacira offers three main products: EXPAREL, ZILRETTA, and ioveraº.

What is the focus of Pacira's mission?

Pacira aims to provide non-opioid treatment options and reduce overreliance on opioids.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

1.14B
45.13M
2.15%
114.51%
10.29%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA